Karin Teien Lande

  • Reseach technologist; MSc
  • +47 22 78 13 52; 970 80 078

Research group

 

Publications 2025

Fjørtoft MO, Garred Ø, Lingjærde OC, Lande KT, Ottestad L, Bergheim IR, OSBREAC, Lømo J, LaMont C, Myklebust JH, Russnes H, Huse K, Rye IH (2025)
Single-cell analysis reveals tumour size as a key driver of immune cell profile alterations in primary breast tumours and corresponding lymph nodes
BJC Rep, 3 (1), 35
DOI 10.1038/s44276-025-00152-3, PubMed 40394379

Lindemann K, Siegenthaler F, Lande KT, Casas-Arozamena C, Nebdal D, Rau TT, Hoivik EA, Mueller MD, Gold RM, Imboden S, Davidson B, Krakstad C, Sørlie T (2025)
Prognostic value of assessing ctDNA in patients with endometrial carcinoma - an international multicenter study
Gynecol Oncol, 195, 98-105
DOI 10.1016/j.ygyno.2025.03.002, PubMed 40081113

Publications 2024

Cun HT, Bernard L, Lande KT, Lawson BC, Nesbakken AJ, Davidson B, Lindemann K, Fellman B, Sørlie T, Soliman PT, Eriksson AGZ (2024)
Comprehensive molecular characterization of early stage grade 3 endometrioid endometrial adenocarcinoma
Gynecol Oncol, 189, 138-145
DOI 10.1016/j.ygyno.2024.07.677, PubMed 39126895